Q1 EPS Forecast for Monogram Orthopaedics Raised by Analyst

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Stock analysts at Roth Capital upped their Q1 2025 earnings estimates for shares of Monogram Orthopaedics in a research report issued to clients and investors on Thursday, March 13th. Roth Capital analyst J. Wittes now forecasts that the company will earn ($0.10) per share for the quarter, up from their previous estimate of ($0.11). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Roth Capital also issued estimates for Monogram Orthopaedics’ Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.39) EPS, FY2025 earnings at ($0.70) EPS, Q1 2026 earnings at ($0.11) EPS, Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.09) EPS, Q4 2026 earnings at ($0.30) EPS, FY2026 earnings at ($0.63) EPS and FY2027 earnings at ($0.24) EPS.

Monogram Orthopaedics (NASDAQ:MGRM) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03.

Separately, Roth Mkm assumed coverage on Monogram Orthopaedics in a report on Monday, December 9th. They issued a “buy” rating and a $4.00 price objective on the stock.

Monogram Orthopaedics Price Performance

Shares of MGRM stock opened at $3.67 on Monday. The company has a 50-day moving average of $2.56 and a two-hundred day moving average of $2.49. The firm has a market cap of $129.51 million, a PE ratio of -7.81 and a beta of 1.66. Monogram Orthopaedics has a 1-year low of $1.53 and a 1-year high of $4.90.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC increased its holdings in Monogram Orthopaedics by 7.7% in the fourth quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock valued at $537,000 after buying an additional 16,234 shares during the last quarter. Northern Trust Corp boosted its position in shares of Monogram Orthopaedics by 110.6% during the 4th quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after acquiring an additional 24,088 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings in shares of Monogram Orthopaedics by 21.5% in the 4th quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company’s stock valued at $99,000 after acquiring an additional 7,366 shares during the last quarter. Fiduciary Family Office LLC acquired a new stake in shares of Monogram Orthopaedics during the 4th quarter worth about $70,000. Finally, State Street Corp purchased a new stake in Monogram Orthopaedics during the third quarter worth approximately $62,000. 0.45% of the stock is currently owned by hedge funds and other institutional investors.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.